These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 8497846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection.
    Dol F, Houin G, Dupouy D, Cadroy Y, Caranobe C, Gabaig AM, Mardiguian J, Sié P, Boneu B.
    Thromb Haemost; 1988 Apr 08; 59(2):255-8. PubMed ID: 3388296
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and pharmacodynamics of dermatan sulfate after intravenous and intramuscular administration to healthy volunteers.
    Blardi P, Messa GL, Urso R, Di Perri T.
    Int J Clin Pharmacol Res; 1993 Apr 08; 13(4):231-8. PubMed ID: 8150550
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb 08; 46(2):114-27. PubMed ID: 8720299
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of guanosine in rats following intravenous or intramuscular administration of a 1:1 mixture of guanosine and acriflavine, a potential antitumor agent.
    Shin DH, Choi KS, Cho BS, Song S, Moon DC, Hong JT, Lee CK, Chung YB.
    Arch Pharm Res; 2008 Oct 08; 31(10):1347-53. PubMed ID: 18958427
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low molecular weight dermatan sulphate (Desmin 370) does not cross the ovine placenta.
    Dawes J, Lumbers ER.
    Br J Haematol; 1993 May 08; 84(1):90-4. PubMed ID: 8338783
    [Abstract] [Full Text] [Related]

  • 17. Metabolic fate of partially depolymerized shark chondroitin sulfate in man.
    Ronca G, Conte A.
    Int J Clin Pharmacol Res; 1993 May 08; 13 Suppl():27-34. PubMed ID: 7995679
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cephalexin in calves after intravenous and subcutaneous administration.
    Garg SK, Chaudhary RK, Srivastava AK.
    Acta Vet Hung; 1996 May 08; 44(2):195-201. PubMed ID: 8908743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.